Ameriprise’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
Ameriprise's OTLK Position: Q3 2026 in Review
Ameriprise opened a new position in Outlook Therapeutics (OTLK) in Q3 2026: 5,050,505 shares worth $2.9M. The stake represents ﹤0.01% of the portfolio and ranks #2885 among its holdings.
81 funds tracked by Wall St. Rank hold OTLK as of Q3 2026.
- Ameriprise held 5,050,505 shares of Outlook Therapeutics worth $2.9M as of Q3 2026.
- Outlook Therapeutics was a new Ameriprise position in Q3 2026.
- Outlook Therapeutics made up ﹤0.01% of Ameriprise's portfolio in Q3 2026, its #2885 holding.
- 81 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q3 2026.
Based on Ameriprise's 13F filing for Q3 2026, filed 16 Nov 2026.